Literature DB >> 22091816

Ventricular enlargement in new-onset pediatric epilepsies.

Daren C Jackson1, William Irwin, Kevin Dabbs, Jack J Lin, Jana E Jones, David A Hsu, Carl E Stafstrom, Michael Seidenberg, Bruce P Hermann.   

Abstract

PURPOSE: To examine baseline and prospective (2-year) changes in third, fourth, and lateral ventricle volumes in children with new-onset idiopathic epilepsies and controls (age 8-18 years).
METHODS: Structural magnetic resonance imaging (MRI) were collected from children with idiopathic generalized epilepsy (IGE, n = 29), idiopathic localization-related epilepsy (ILRE, n = 30), and healthy controls (HCs, n = 49). Volumes of the third, fourth, and lateral ventricles were derived and compared across groups, followed by shape analyses, to identify specific regions of ventricular abnormality. Of the initial cohort, a consecutive sample of 71 children returned 2 years later for reimaging and determination of progressive changes in the ventricular system. KEY
FINDINGS: At baseline, children with new-onset IGE had significantly larger lateral and third ventricle volumes relative to the HC group. In addition, lateral ventricle enlargement in IGE was significantly greater compared to new-onset ILRE. Shape analysis of the lateral ventricles revealed that volume expansion in IGE was selective for the anterior horn, a region surrounded by the lateral and medial frontal lobes as well as basal ganglia. These abnormalities did not progress over a 2-year interval. SIGNIFICANCE: Abnormalities in brain development prior to onset and diagnosis of epilepsy are evident and reflected in expansion of the ventricular system, especially among children with IGE. These abnormalities appear to represent an antecedent and possibly static finding given the lack of progressive ventricular expansion over the 2-year interval following diagnosis and treatment. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Year:  2011        PMID: 22091816      PMCID: PMC3347640          DOI: 10.1111/j.1528-1167.2011.03323.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  25 in total

1.  Microstructural and volumetric abnormalities of the putamen in juvenile myoclonic epilepsy.

Authors:  Simon S Keller; Tobias Ahrens; Siawoosh Mohammadi; Gabriel Möddel; Harald Kugel; E Bernd Ringelstein; Michael Deppe
Journal:  Epilepsia       Date:  2011-06-02       Impact factor: 5.864

2.  Progressive lateral ventricular enlargement in schizophrenia: a meta-analysis of longitudinal MRI studies.

Authors:  Matthew J Kempton; Daniel Stahl; Steven C R Williams; Lynn E DeLisi
Journal:  Schizophr Res       Date:  2010-05-26       Impact factor: 4.939

3.  Focal structural changes and cognitive dysfunction in juvenile myoclonic epilepsy.

Authors:  J O'Muircheartaigh; C Vollmar; G J Barker; V Kumari; M R Symms; P Thompson; J S Duncan; M J Koepp; M P Richardson
Journal:  Neurology       Date:  2011-01-04       Impact factor: 9.910

4.  Behavior problems in children before first recognized seizures.

Authors:  J K Austin; J Harezlak; D W Dunn; G A Huster; D F Rose; W T Ambrosius
Journal:  Pediatrics       Date:  2001-01       Impact factor: 7.124

5.  Diffusion and volumetry abnormalities in subcortical nuclei of patients with absence seizures.

Authors:  Cheng Luo; Yang Xia; Qifu Li; Kaiqing Xue; Yongxiu Lai; Qiyong Gong; Dong Zhou; Dezhong Yao
Journal:  Epilepsia       Date:  2011-03-31       Impact factor: 5.864

6.  A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology.

Authors:  J Engel
Journal:  Epilepsia       Date:  2001-06       Impact factor: 5.864

7.  Brain abnormalities in early-onset schizophrenia spectrum disorder observed with statistical parametric mapping of structural magnetic resonance images.

Authors:  E R Sowell; J Levitt; P M Thompson; C J Holmes; R E Blanton; D S Kornsand; R Caplan; J McCracken; R Asarnow; A W Toga
Journal:  Am J Psychiatry       Date:  2000-09       Impact factor: 18.112

8.  Neuropsychological status at seizure onset in children: risk factors for early cognitive deficits.

Authors:  P S Fastenau; C S Johnson; S M Perkins; A W Byars; T J deGrauw; J K Austin; D W Dunn
Journal:  Neurology       Date:  2009-08-12       Impact factor: 9.910

9.  Combining shape and connectivity analysis: an MRI study of thalamic degeneration in Alzheimer's disease.

Authors:  Mojtaba Zarei; Brian Patenaude; Jessica Damoiseaux; Ciro Morgese; Steve Smith; Paul M Matthews; Frederik Barkhof; Serge A R B Rombouts; Ernesto Sanz-Arigita; Mark Jenkinson
Journal:  Neuroimage       Date:  2009-09-08       Impact factor: 6.556

10.  Motor system hyperconnectivity in juvenile myoclonic epilepsy: a cognitive functional magnetic resonance imaging study.

Authors:  Christian Vollmar; Jonathan O'Muircheartaigh; Gareth J Barker; Mark R Symms; Pamela Thompson; Veena Kumari; John S Duncan; Dieter Janz; Mark P Richardson; Matthias J Koepp
Journal:  Brain       Date:  2011-06       Impact factor: 13.501

View more
  13 in total

1.  Human and rodent temporal lobe epilepsy is characterized by changes in O-GlcNAc homeostasis that can be reversed to dampen epileptiform activity.

Authors:  Richard G Sánchez; R Ryley Parrish; Megan Rich; William M Webb; Roxanne M Lockhart; Kazuhito Nakao; Lara Ianov; Susan C Buckingham; Devin R Broadwater; Alistair Jenkins; Nihal C de Lanerolle; Mark Cunningham; Tore Eid; Kristen Riley; Farah D Lubin
Journal:  Neurobiol Dis       Date:  2019-01-06       Impact factor: 5.996

2.  Region-specific changes in brain diffusivity in fetal isolated mild ventriculomegaly.

Authors:  Gal Yaniv; Eldad Katorza; Ronen Bercovitz; Dafi Bergman; Gahl Greenberg; Anat Biegon; Chen Hoffmann
Journal:  Eur Radiol       Date:  2015-07-02       Impact factor: 5.315

Review 3.  Starting at the beginning: the neuropsychological status of children with new-onset epilepsies.

Authors:  Bruce P Hermann; Jana E Jones; Daren C Jackson; Michael Seidenberg
Journal:  Epileptic Disord       Date:  2012-03       Impact factor: 1.819

4.  Pharmacoresistance and cognitive delays in children: a bidirectional relationship.

Authors:  Lara Jehi
Journal:  Epilepsy Curr       Date:  2013-03       Impact factor: 7.500

Review 5.  Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan.

Authors:  Jack J Lin; Marco Mula; Bruce P Hermann
Journal:  Lancet       Date:  2012-09-29       Impact factor: 79.321

6.  Morphometric abnormalities of the lateral ventricles in methamphetamine-dependent subjects.

Authors:  Hyeonseok S Jeong; Sunho Lee; Sujung Yoon; Jiyoung J Jung; Han Byul Cho; Binna N Kim; Jiyoung Ma; Eun Ko; Jooyeon Jamie Im; Soonhyun Ban; Perry F Renshaw; In Kyoon Lyoo
Journal:  Drug Alcohol Depend       Date:  2013-06-12       Impact factor: 4.492

Review 7.  Imaging and genetics of language and cognition in pediatric epilepsy.

Authors:  Laura Addis; Jack J Lin; Deb K Pal; Bruce Hermann; Rochelle Caplan
Journal:  Epilepsy Behav       Date:  2012-10-30       Impact factor: 2.937

8.  A mechanism of rapidly reversible cerebral ventricular enlargement independent of tissue atrophy.

Authors:  Natalie M Zahr; Dirk Mayer; Torsten Rohlfing; Juan Orduna; Richard Luong; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropsychopharmacology       Date:  2013-01-10       Impact factor: 7.853

9.  Morphometric changes in lateral ventricles of patients with recent-onset type 2 diabetes mellitus.

Authors:  Junghyun H Lee; Sujung Yoon; Perry F Renshaw; Tae-Suk Kim; Jiyoung J Jung; Yera Choi; Binna N Kim; Alan M Jacobson; In Kyoon Lyoo
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

Review 10.  Chronic traumatic encephalopathy neuropathology might not be inexorably progressive or unique to repetitive neurotrauma.

Authors:  Grant L Iverson; Andrew J Gardner; Sandy R Shultz; Gary S Solomon; Paul McCrory; Ross Zafonte; George Perry; Lili-Naz Hazrati; C Dirk Keene; Rudolph J Castellani
Journal:  Brain       Date:  2019-12-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.